POMC and congenital adrenal hyperplasia: For CAH patients, cortisol replacement therapy with oral hydrocortisone (synthetic cortisol) is the most commonly adopted therapeutic strategy, aiming to mimic cortisol's physiological circadian rhythm and thus reducing ACTH and androgen overproduction [1, 5].